Green Earth Institute Co., Ltd.
Stock Price Chart
2026/10/08 19:22 UpdatedPrice Trend
2026/10/08 19:22 UpdatedPrice & Trading Details
2026/10/08 19:22 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥585M | ¥897M | ¥1,003M | ¥1,075M |
| Gross Profit | ¥330M | ¥419M | ¥442M | ¥642M |
| Operating Income | -¥99M | -¥107M | -¥149M | -¥4M |
| Pretax Income | -¥223M | -¥107M | -¥130M | ¥158M |
| Net Income | -¥234M | -¥112M | -¥134M | ¥127M |
| EPS | -¥22.33 | -¥9.97 | -¥11.87 | ¥11.27 |
| Operating Margin | -16.93% | -11.91% | -14.84% | -0.39% |
| Balance Sheet | ||||
| Total Assets | ¥3,384M | ¥2,672M | ¥2,736M | ¥2,967M |
| Total Equity | ¥2,218M | ¥2,110M | ¥1,975M | ¥2,106M |
| Total Liabilities | ¥1,167M | ¥562M | ¥761M | ¥861M |
| Cash | ¥2,741M | ¥2,401M | ¥2,274M | ¥2,060M |
| Interest-bearing Debt | ¥196M | ¥206M | ¥157M | ¥147M |
| Equity Ratio | 65.53% | 78.98% | 72.18% | 70.97% |
| D/E Ratio | 0.09 | 0.10 | 0.08 | 0.07 |
| Cash Flow | ||||
| Operating CF | ¥338M | -¥321M | ¥3M | -¥49M |
| Investing CF | -¥36M | -¥13M | -¥81M | -¥156M |
| Financing CF | ¥1,613M | -¥5M | -¥49M | -¥9M |
| Free CF | ¥284M | -¥335M | -¥78M | -¥200M |
| Efficiency | ||||
| ROE | -10.57% | -5.32% | -6.78% | 6.05% |
| ROA | -6.92% | -4.20% | -4.89% | 4.29% |
Latest IR Information
-
Notice Regarding Change in Major Shareholders and Major Shareholder Who Is the Largest Shareholder
As of September 30, 2026, changes in major shareholders and the largest shareholder were confirmed. SBI Securities remains in the position of major shareholder after the change; there is no impact on performance or management structure.
Read more -
Addition of Enzyme Evaluation Items in Joint Research and Development Agreement Toward Commercialization of the Biorefinery
Addition of enzyme evaluation items in the joint R&D agreement with Daio Paper. Newly added evaluation and usage conditions for domestic and international enzymes to optimize continuous simultaneous saccharification and fermentation (GWE process). The total development cost for 2025–2027 is...
Read more -
NEDO Bio Manufacturing Revolution Promotion Project: Addition of Enzyme Evaluation Project
Discloses GEI's planned addition of enzyme evaluation under NEDO's Bio Manufacturing Revolution Promotion Project. Additional cost total is 43.8 million yen, spanning five years from FY2026 to FY2030. No direct impact on FY2026 earnings.
Read more -
Notice on Approval for Market Segment Change of The Tokyo Stock Exchange
Upon approval of market segment change, plans to transition from the Growth Market to the Standard Market. To realize the mid-to-long-term vision “GEI that earns,” aiming to become an integrated bio-manufacturing platform business builder. Outlines expansion plans for 2027 onward...
Read more -
Notice Regarding the Implementation of Shareholder Benefits Commemorating Market Segment Change
commemorative shareholder benefits to mark the market segment change. Eligible shareholders are those listed on the shareholder registry as of the end of September and owning at least 100 shares. Benefit is a QUO card worth 1,000 yen; shipping is...
Read more
Latest News (5 items)
Company Information
About
Green Earth Institute Co., Ltd. engages in the production and sale of carbon neutral biofuels and green chemicals in Japan and internationally. The company offers jet fuels; bioplastics used for food, feed, and cosmetic additives; and ethanol for cosmetics. Green Earth Institute Co., Ltd. was incorporated in 2011 and is headquartered in Tokyo, Japan.
